The global Alcoholic Hepatitis Therapeutic market is projected to grow from US$ 2824.4 million in 2023 to US$ 3839.4 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.

Alcoholic Hepatitis Therapeutic Market

Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can’t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.

Market Analysis and Insights: Global Alcoholic Hepatitis Therapeutic Market

The global alcoholic hepatitis therapeutics market is expected to witness a favorable growth during the forecast period. Increasing incidence of liver diseases and high success rate of pipeline drugs are the major factors which increase global alcoholic hepatitis market. Moreover high adoption rate for novel therapeutic products and increasing prevalence of alcoholic liver disease are some other factors that are expected to fuel the demand of global alcoholic hepatitis market. Global alcoholic hepatitis market shows potential to be expanding and lucrative field due to increasing merger and acquisitions among pharmaceutical companies to develop advance therapies for treating liver diseases. Furthermore, increased focus on retaining best quality of life is one the factor contributing to the growth of the market. However increasing health care expenditure, stringent reimbursement policies and high development cost are some factors that might hinder the growth of alcoholic hepatitis therapeutics market in forecast period.

Report Includes

This report presents an overview of global market for Alcoholic Hepatitis Therapeutic market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Alcoholic Hepatitis Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Alcoholic Hepatitis Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alcoholic Hepatitis Therapeutic revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Alcoholic Hepatitis Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Alcoholic Hepatitis Therapeutic revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Alkermes, Conatus pharmaceuticals, Dainippon sumitomo pharma, Generon corporation, Immuron limited, Lupin Laboratories, Intercept Pharmaceuticals, Teva Pharmaceuticals and Sanofi-Aventis, etc.

Scope of Alcoholic Hepatitis Therapeutic Market Report

Report Metric	Details
Report Name	Alcoholic Hepatitis Therapeutic Market
Accounted market size in 2023	US$ 2824.4 million
Forecasted market size in 2029	US$ 3839.4 million
CAGR	5.3
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Monoclonal Antibodies Caspase Protease Inhibitor Corticosteroids Hemorheologic Agents Anabolic Steroids Hepatotropic Hormones Sulfhydryl Agents Others
Segment by Application	Hospitals and Clinics Research and Development
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alkermes, Conatus pharmaceuticals, Dainippon sumitomo pharma, Generon corporation, Immuron limited, Lupin Laboratories, Intercept Pharmaceuticals, Teva Pharmaceuticals, Sanofi-Aventis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Alcoholic Hepatitis Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alcoholic Hepatitis Therapeutic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alcoholic Hepatitis Therapeutic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Alcoholic Hepatitis Therapeutic Market growing?

Ans: The Alcoholic Hepatitis Therapeutic Market witnessing a CAGR of 5.3 during the forecast period 2023-2029.

What is the Alcoholic Hepatitis Therapeutic Market size in 2029?

Ans: The global Alcoholic Hepatitis Therapeutic market is projected to grow from US$ 2824.4 million in 2023 to US$ 3839.4 million by 2029, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.

Who are the main players in the Alcoholic Hepatitis Therapeutic Market report?

Ans: The main players in the Alcoholic Hepatitis Therapeutic Market are Alkermes, Conatus pharmaceuticals, Dainippon sumitomo pharma, Generon corporation, Immuron limited, Lupin Laboratories, Intercept Pharmaceuticals, Teva Pharmaceuticals, Sanofi-Aventis

What are the Application segmentation covered in the Alcoholic Hepatitis Therapeutic Market report?

Ans: The Applications covered in the Alcoholic Hepatitis Therapeutic Market report are Hospitals and Clinics, Research and Development

What are the Type segmentation covered in the Alcoholic Hepatitis Therapeutic Market report?

Ans: The Types covered in the Alcoholic Hepatitis Therapeutic Market report are Monoclonal Antibodies, Caspase Protease Inhibitor, Corticosteroids, Hemorheologic Agents, Anabolic Steroids, Hepatotropic Hormones, Sulfhydryl Agents, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Monoclonal Antibodies

1.2.3 Caspase Protease Inhibitor

1.2.4 Corticosteroids

1.2.5 Hemorheologic Agents

1.2.6 Anabolic Steroids

1.2.7 Hepatotropic Hormones

1.2.8 Sulfhydryl Agents

1.2.9 Others

1.3 Market by Application

1.3.1 Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospitals and Clinics

1.3.3 Research and Development

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Alcoholic Hepatitis Therapeutic Market Perspective (2018-2029)

2.2 Global Alcoholic Hepatitis Therapeutic Growth Trends by Region

2.2.1 Alcoholic Hepatitis Therapeutic Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Alcoholic Hepatitis Therapeutic Historic Market Size by Region (2018-2023)

2.2.3 Alcoholic Hepatitis Therapeutic Forecasted Market Size by Region (2024-2029)

2.3 Alcoholic Hepatitis Therapeutic Market Dynamics

2.3.1 Alcoholic Hepatitis Therapeutic Industry Trends

2.3.2 Alcoholic Hepatitis Therapeutic Market Drivers

2.3.3 Alcoholic Hepatitis Therapeutic Market Challenges

2.3.4 Alcoholic Hepatitis Therapeutic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Alcoholic Hepatitis Therapeutic by Players

3.1.1 Global Alcoholic Hepatitis Therapeutic Revenue by Players (2018-2023)

3.1.2 Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Players (2018-2023)

3.2 Global Alcoholic Hepatitis Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Alcoholic Hepatitis Therapeutic, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio

3.4.1 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alcoholic Hepatitis Therapeutic Revenue in 2022

3.5 Global Key Players of Alcoholic Hepatitis Therapeutic Head office and Area Served

3.6 Global Key Players of Alcoholic Hepatitis Therapeutic, Product and Application

3.7 Global Key Players of Alcoholic Hepatitis Therapeutic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Alcoholic Hepatitis Therapeutic Breakdown Data by Type

4.1 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Type (2018-2023)

4.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Type (2024-2029)

5 Alcoholic Hepatitis Therapeutic Breakdown Data by Application

5.1 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Application (2018-2023)

5.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Alcoholic Hepatitis Therapeutic Market Size (2018-2029)

6.2 North America Alcoholic Hepatitis Therapeutic Market Size by Type

6.2.1 North America Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)

6.2.2 North America Alcoholic Hepatitis Therapeutic Market Size by Type (2024-2029)

6.2.3 North America Alcoholic Hepatitis Therapeutic Market Share by Type (2018-2029)

6.3 North America Alcoholic Hepatitis Therapeutic Market Size by Application

6.3.1 North America Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)

6.3.2 North America Alcoholic Hepatitis Therapeutic Market Size by Application (2024-2029)

6.3.3 North America Alcoholic Hepatitis Therapeutic Market Share by Application (2018-2029)

6.4 North America Alcoholic Hepatitis Therapeutic Market Size by Country

6.4.1 North America Alcoholic Hepatitis Therapeutic Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023)

6.4.3 North America Alcoholic Hepatitis Therapeutic Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Alcoholic Hepatitis Therapeutic Market Size (2018-2029)

7.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Type

7.2.1 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)

7.2.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2024-2029)

7.2.3 Europe Alcoholic Hepatitis Therapeutic Market Share by Type (2018-2029)

7.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Application

7.3.1 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)

7.3.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2024-2029)

7.3.3 Europe Alcoholic Hepatitis Therapeutic Market Share by Application (2018-2029)

7.4 Europe Alcoholic Hepatitis Therapeutic Market Size by Country

7.4.1 Europe Alcoholic Hepatitis Therapeutic Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023)

7.4.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Alcoholic Hepatitis Therapeutic Market Size (2018-2029)

8.2 China Alcoholic Hepatitis Therapeutic Market Size by Type

8.2.1 China Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)

8.2.2 China Alcoholic Hepatitis Therapeutic Market Size by Type (2024-2029)

8.2.3 China Alcoholic Hepatitis Therapeutic Market Share by Type (2018-2029)

8.3 China Alcoholic Hepatitis Therapeutic Market Size by Application

8.3.1 China Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)

8.3.2 China Alcoholic Hepatitis Therapeutic Market Size by Application (2024-2029)

8.3.3 China Alcoholic Hepatitis Therapeutic Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Alcoholic Hepatitis Therapeutic Market Size (2018-2029)

9.2 Asia Alcoholic Hepatitis Therapeutic Market Size by Type

9.2.1 Asia Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)

9.2.2 Asia Alcoholic Hepatitis Therapeutic Market Size by Type (2024-2029)

9.2.3 Asia Alcoholic Hepatitis Therapeutic Market Share by Type (2018-2029)

9.3 Asia Alcoholic Hepatitis Therapeutic Market Size by Application

9.3.1 Asia Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)

9.3.2 Asia Alcoholic Hepatitis Therapeutic Market Size by Application (2024-2029)

9.3.3 Asia Alcoholic Hepatitis Therapeutic Market Share by Application (2018-2029)

9.4 Asia Alcoholic Hepatitis Therapeutic Market Size by Region

9.4.1 Asia Alcoholic Hepatitis Therapeutic Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Alcoholic Hepatitis Therapeutic Market Size by Region (2018-2023)

9.4.3 Asia Alcoholic Hepatitis Therapeutic Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Type

10.2.1 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Application

10.3.1 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Country

10.4.1 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Alkermes

11.1.1 Alkermes Company Details

11.1.2 Alkermes Business Overview

11.1.3 Alkermes Alcoholic Hepatitis Therapeutic Introduction

11.1.4 Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023)

11.1.5 Alkermes Recent Developments

11.2 Conatus pharmaceuticals

11.2.1 Conatus pharmaceuticals Company Details

11.2.2 Conatus pharmaceuticals Business Overview

11.2.3 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction

11.2.4 Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023)

11.2.5 Conatus pharmaceuticals Recent Developments

11.3 Dainippon sumitomo pharma

11.3.1 Dainippon sumitomo pharma Company Details

11.3.2 Dainippon sumitomo pharma Business Overview

11.3.3 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Introduction

11.3.4 Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023)

11.3.5 Dainippon sumitomo pharma Recent Developments

11.4 Generon corporation

11.4.1 Generon corporation Company Details

11.4.2 Generon corporation Business Overview

11.4.3 Generon corporation Alcoholic Hepatitis Therapeutic Introduction

11.4.4 Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023)

11.4.5 Generon corporation Recent Developments

11.5 Immuron limited

11.5.1 Immuron limited Company Details

11.5.2 Immuron limited Business Overview

11.5.3 Immuron limited Alcoholic Hepatitis Therapeutic Introduction

11.5.4 Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023)

11.5.5 Immuron limited Recent Developments

11.6 Lupin Laboratories

11.6.1 Lupin Laboratories Company Details

11.6.2 Lupin Laboratories Business Overview

11.6.3 Lupin Laboratories Alcoholic Hepatitis Therapeutic Introduction

11.6.4 Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023)

11.6.5 Lupin Laboratories Recent Developments

11.7 Intercept Pharmaceuticals

11.7.1 Intercept Pharmaceuticals Company Details

11.7.2 Intercept Pharmaceuticals Business Overview

11.7.3 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction

11.7.4 Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023)

11.7.5 Intercept Pharmaceuticals Recent Developments

11.8 Teva Pharmaceuticals

11.8.1 Teva Pharmaceuticals Company Details

11.8.2 Teva Pharmaceuticals Business Overview

11.8.3 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction

11.8.4 Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023)

11.8.5 Teva Pharmaceuticals Recent Developments

11.9 Sanofi-Aventis

11.9.1 Sanofi-Aventis Company Details

11.9.2 Sanofi-Aventis Business Overview

11.9.3 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Introduction

11.9.4 Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023)

11.9.5 Sanofi-Aventis Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Alkermes plc

Conatus Pharmaceuticals

Dainippon sumitomo pharma

Generon corporation

Immuron

Lupin Laboratories

Intercept Pharmaceuticals

Teva Pharmaceuticals

Sanofi Aventis

List of Tables

Table 1. Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Caspase Protease Inhibitor

Table 4. Key Players of Corticosteroids

Table 5. Key Players of Hemorheologic Agents

Table 6. Key Players of Anabolic Steroids

Table 7. Key Players of Hepatotropic Hormones

Table 8. Key Players of Sulfhydryl Agents

Table 9. Key Players of Others

Table 10. Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 11. Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 12. Global Alcoholic Hepatitis Therapeutic Market Size by Region (2018-2023) & (US$ Million)

Table 13. Global Alcoholic Hepatitis Therapeutic Market Share by Region (2018-2023)

Table 14. Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 15. Global Alcoholic Hepatitis Therapeutic Market Share by Region (2024-2029)

Table 16. Alcoholic Hepatitis Therapeutic Market Trends

Table 17. Alcoholic Hepatitis Therapeutic Market Drivers

Table 18. Alcoholic Hepatitis Therapeutic Market Challenges

Table 19. Alcoholic Hepatitis Therapeutic Market Restraints

Table 20. Global Alcoholic Hepatitis Therapeutic Revenue by Players (2018-2023) & (US$ Million)

Table 21. Global Alcoholic Hepatitis Therapeutic Revenue Share by Players (2018-2023)

Table 22. Global Top Alcoholic Hepatitis Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alcoholic Hepatitis Therapeutic as of 2022)

Table 23. Global Alcoholic Hepatitis Therapeutic Industry Ranking 2021 VS 2022 VS 2023

Table 24. Global 5 Largest Players Market Share by Alcoholic Hepatitis Therapeutic Revenue (CR5 and HHI) & (2018-2023)

Table 25. Global Key Players of Alcoholic Hepatitis Therapeutic, Headquarters and Area Served

Table 26. Global Key Players of Alcoholic Hepatitis Therapeutic, Product and Application

Table 27. Global Key Players of Alcoholic Hepatitis Therapeutic, Product and Application

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & (US$ Million)

Table 30. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Type (2018-2023)

Table 31. Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 32. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Type (2024-2029)

Table 33. Global Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & (US$ Million)

Table 34. Global Alcoholic Hepatitis Therapeutic Revenue Share by Application (2018-2023)

Table 35. Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 36. Global Alcoholic Hepatitis Therapeutic Revenue Share by Application (2024-2029)

Table 37. North America Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & (US$ Million)

Table 38. North America Alcoholic Hepatitis Therapeutic Market Size by Type (2024-2029) & (US$ Million)

Table 39. North America Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & (US$ Million)

Table 40. North America Alcoholic Hepatitis Therapeutic Market Size by Application (2024-2029) & (US$ Million)

Table 41. North America Alcoholic Hepatitis Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 42. North America Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023) & (US$ Million)

Table 43. North America Alcoholic Hepatitis Therapeutic Market Size by Country (2024-2029) & (US$ Million)

Table 44. Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & (US$ Million)

Table 45. Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2024-2029) & (US$ Million)

Table 46. Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & (US$ Million)

Table 47. Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2024-2029) & (US$ Million)

Table 48. Europe Alcoholic Hepatitis Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 49. Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023) & (US$ Million)

Table 50. Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2024-2029) & (US$ Million)

Table 51. China Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & (US$ Million)

Table 52. China Alcoholic Hepatitis Therapeutic Market Size by Type (2024-2029) & (US$ Million)

Table 53. China Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & (US$ Million)

Table 54. China Alcoholic Hepatitis Therapeutic Market Size by Application (2024-2029) & (US$ Million)

Table 55. Asia Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & (US$ Million)

Table 56. Asia Alcoholic Hepatitis Therapeutic Market Size by Type (2024-2029) & (US$ Million)

Table 57. Asia Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & (US$ Million)

Table 58. Asia Alcoholic Hepatitis Therapeutic Market Size by Application (2024-2029) & (US$ Million)

Table 59. Asia Alcoholic Hepatitis Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 60. Asia Alcoholic Hepatitis Therapeutic Market Size by Region (2018-2023) & (US$ Million)

Table 61. Asia Alcoholic Hepatitis Therapeutic Market Size by Region (2024-2029) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2018-2023) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2024-2029) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2018-2023) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2024-2029) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 67. Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2018-2023) & (US$ Million)

Table 68. Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2024-2029) & (US$ Million)

Table 69. Alkermes Company Details

Table 70. Alkermes Business Overview

Table 71. Alkermes Alcoholic Hepatitis Therapeutic Product

Table 72. Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023) & (US$ Million)

Table 73. Alkermes Recent Developments

Table 74. Conatus pharmaceuticals Company Details

Table 75. Conatus pharmaceuticals Business Overview

Table 76. Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Product

Table 77. Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023) & (US$ Million)

Table 78. Conatus pharmaceuticals Recent Developments

Table 79. Dainippon sumitomo pharma Company Details

Table 80. Dainippon sumitomo pharma Business Overview

Table 81. Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Product

Table 82. Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023) & (US$ Million)

Table 83. Dainippon sumitomo pharma Recent Developments

Table 84. Generon corporation Company Details

Table 85. Generon corporation Business Overview

Table 86. Generon corporation Alcoholic Hepatitis Therapeutic Product

Table 87. Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023) & (US$ Million)

Table 88. Generon corporation Recent Developments

Table 89. Immuron limited Company Details

Table 90. Immuron limited Business Overview

Table 91. Immuron limited Alcoholic Hepatitis Therapeutic Product

Table 92. Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023) & (US$ Million)

Table 93. Immuron limited Recent Developments

Table 94. Lupin Laboratories Company Details

Table 95. Lupin Laboratories Business Overview

Table 96. Lupin Laboratories Alcoholic Hepatitis Therapeutic Product

Table 97. Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023) & (US$ Million)

Table 98. Lupin Laboratories Recent Developments

Table 99. Intercept Pharmaceuticals Company Details

Table 100. Intercept Pharmaceuticals Business Overview

Table 101. Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Product

Table 102. Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023) & (US$ Million)

Table 103. Intercept Pharmaceuticals Recent Developments

Table 104. Teva Pharmaceuticals Company Details

Table 105. Teva Pharmaceuticals Business Overview

Table 106. Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Product

Table 107. Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023) & (US$ Million)

Table 108. Teva Pharmaceuticals Recent Developments

Table 109. Sanofi-Aventis Company Details

Table 110. Sanofi-Aventis Business Overview

Table 111. Sanofi-Aventis Alcoholic Hepatitis Therapeutic Product

Table 112. Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2018-2023) & (US$ Million)

Table 113. Sanofi-Aventis Recent Developments

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Alcoholic Hepatitis Therapeutic Market Share by Type: 2022 VS 2029

Figure 3. Monoclonal Antibodies Features

Figure 4. Caspase Protease Inhibitor Features

Figure 5. Corticosteroids Features

Figure 6. Hemorheologic Agents Features

Figure 7. Anabolic Steroids Features

Figure 8. Hepatotropic Hormones Features

Figure 9. Sulfhydryl Agents Features

Figure 10. Others Features

Figure 11. Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 12. Global Alcoholic Hepatitis Therapeutic Market Share by Application: 2022 VS 2029

Figure 13. Hospitals and Clinics Case Studies

Figure 14. Research and Development Case Studies

Figure 15. Alcoholic Hepatitis Therapeutic Report Years Considered

Figure 16. Global Alcoholic Hepatitis Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 17. Global Alcoholic Hepatitis Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 18. Global Alcoholic Hepatitis Therapeutic Market Share by Region: 2022 VS 2029

Figure 19. Global Alcoholic Hepatitis Therapeutic Market Share by Players in 2022

Figure 20. Global Top Alcoholic Hepatitis Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alcoholic Hepatitis Therapeutic as of 2022)

Figure 21. The Top 10 and 5 Players Market Share by Alcoholic Hepatitis Therapeutic Revenue in 2022

Figure 22. North America Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. North America Alcoholic Hepatitis Therapeutic Market Share by Type (2018-2029)

Figure 24. North America Alcoholic Hepatitis Therapeutic Market Share by Application (2018-2029)

Figure 25. North America Alcoholic Hepatitis Therapeutic Market Share by Country (2018-2029)

Figure 26. United States Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. Canada Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Europe Alcoholic Hepatitis Therapeutic Market Size YoY (2018-2029) & (US$ Million)

Figure 29. Europe Alcoholic Hepatitis Therapeutic Market Share by Type (2018-2029)

Figure 30. Europe Alcoholic Hepatitis Therapeutic Market Share by Application (2018-2029)

Figure 31. Europe Alcoholic Hepatitis Therapeutic Market Share by Country (2018-2029)

Figure 32. Germany Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. France Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. U.K. Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. Italy Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Russia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Nordic Countries Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. China Alcoholic Hepatitis Therapeutic Market Size YoY (2018-2029) & (US$ Million)

Figure 39. China Alcoholic Hepatitis Therapeutic Market Share by Type (2018-2029)

Figure 40. China Alcoholic Hepatitis Therapeutic Market Share by Application (2018-2029)

Figure 41. Asia Alcoholic Hepatitis Therapeutic Market Size YoY (2018-2029) & (US$ Million)

Figure 42. Asia Alcoholic Hepatitis Therapeutic Market Share by Type (2018-2029)

Figure 43. Asia Alcoholic Hepatitis Therapeutic Market Share by Application (2018-2029)

Figure 44. Asia Alcoholic Hepatitis Therapeutic Market Share by Region (2018-2029)

Figure 45. Japan Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. South Korea Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. China Taiwan Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Southeast Asia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 49. India Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 50. Australia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Size YoY (2018-2029) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Share by Type (2018-2029)

Figure 53. Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Share by Application (2018-2029)

Figure 54. Middle East, Africa, and Latin America Alcoholic Hepatitis Therapeutic Market Share by Country (2018-2029)

Figure 55. Brazil Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Mexico Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. Turkey Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. Saudi Arabia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 59. Israel Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 60. GCC Countries Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 61. Alkermes Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2018-2023)

Figure 62. Conatus pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2018-2023)

Figure 63. Dainippon sumitomo pharma Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2018-2023)

Figure 64. Generon corporation Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2018-2023)

Figure 65. Immuron limited Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2018-2023)

Figure 66. Lupin Laboratories Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2018-2023)

Figure 67. Intercept Pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2018-2023)

Figure 68. Teva Pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2018-2023)

Figure 69. Sanofi-Aventis Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2018-2023)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Addison's Disease Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-15W2944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cryochambers Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-37W6047

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Drug Repurposing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23J5563

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Consumer mHealth Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-11I6310

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions